News Headlines Article

In war on Alzheimer’s, group deploys new way to enlist
San Francisco Business Times

Like the journey of a thousand miles, the path leading to an Alzheimer’s disease treatment begins with a single step: Getting people through the doors of hundreds of clinical trial sites. Now a program based at the University of California, San Francisco, is teaming up with a global foundation to build out a registry of current and potential Alzheimer’s patients from which the right people can be quickly assigned to the right drug studies.